Brief: Sensorion Shows Protective Effect Of Sens-401 In Hearing Loss Models
June 29 (Reuters) - SENSORION SA ALSEN.PA :
* SENSORION SHOWS PROTECTIVE EFFECT OF SENS-401 IN HEARING
LOSS
MODELS
* CLINICAL STAGE PRODUCT-CANDIDATE SENS-401 DEMONSTRATED
PROTECTIVE EFFECTS IN TWO PRECLINICAL MODELS OF HEARING LOSS
* PRODUCT IS EXPECTED TO ENTER PHASE 2 CLINICAL PROOF OF
CONCEPT
STUDIES IN COMING WEEKS
Source text for Eikon: ID:nGNXc8YSB5
Further company coverage: ALSEN.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Sensorion SA
See all newsEurope Research Roundup: Glencore, Hydro, SIG Group
Europe Research Roundup: Ashmore, Chemring Group, Qinetiq Group
Brief: Sensorion Says CEO Nawal Ouzren To Step Down
Analysis: Trump health policy uncertainty sends biotech sector into deeper slump
Brief: Sensorion Announces EUR 15 Mln Financing, Extending Cash Runway Until End 2025